Brief Information of the Cell Line and Protein
Cell Line ID: CL000011 , CHO
Synonyms
Chinese Hamster Ovary
CHO-ori
Category Spontaneously immortalized cell line
Organism
Cricetulus griseus (Chinese hamster)
Cellosaurus ID
CVCL_0213
Protein ID: PT02587 , Gastrin/cholecystokinin type B receptor
Gene Name CCKBR
Organism Rattus norvegicus, Rat
Protein Classification Membrane receptor
Uniprot ID P30553
Table of Molecular Bioactivities Related to the Cell Line and Protein
Cell Line ID: CL000011  Protein ID: PT02587
 
Compound ID Compound Name Compound Formula
CP0406462
(S)-N-((S)-1-Carbamoyl-2-phenyl-ethyl)-3-((S)-2-{[(S)-2-(2-carboxy-acetylamino)-3-(1H-indol-3-yl)-propionyl]-methyl-amino}-hexanoylamino)-succinamic acid
   Show/Hide
C34H42N6O9
 3
1
EC50 = 0.4 nM
   TI
   LI
   LO
   TS
2
Ki = 0.75 nM
   TI
   LI
   LO
   TS
3
Ki > 3000 nM
   TI
   LI
   LO
   TS
CP0492325
(3S)-4-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-[[(2S)-2-[[(2S)-3-(1H-indol-3-yl)-2-[(2-sulfoacetyl)amino]propanoyl]-methylamino]hexanoyl]amino]-4-oxobutanoic acid
   Show/Hide
C33H42N6O10S
 1
1
EC50 = 0.56 nM
   TI
   LI
   LO
   TS
CP0037352
(3S)-3-[(2S)-2-[(2S)-2-{2-[(2S)-2-[(2S)-2-[(3S)-3-amino-3-formamidopropanoic acid]-3-[4-(sulfooxy)phenyl]propanamido]-4-(methylsulfanyl)butanamido]acetamido}-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-{[(1S)-1-carbamoyl-2-phenylethyl]carbamoyl}propanoic acid
   Show/Hide
C49H62N10O16S3
 3
1
EC50 = 0.63 nM
   TI
   LI
   LO
   TS
2
Ki = 0.6 nM
   TI
   LI
   LO
   TS
3
Ki = 0.7 nM
   TI
   LI
   LO
   TS
CP0062546
(S)-3-{(S)-2-[(S)-2-tert-Butoxycarbonylamino-3-(1H-indol-3-yl)-propionylamino]-4-methylsulfanyl-butyrylamino}-N-((S)-1-carbamoyl-2-phenyl-ethyl)-succinamic acid
   Show/Hide
C34H44N6O8S
 2
1
EC50 = 1 nM
   TI
   LI
   LO
   TS
2
Ki = 9.4 nM
   TI
   LI
   LO
   TS
CP0285916
3-{2-[2-Amino-3-(1H-indol-3-yl)-propionylamino]-4-methylsulfanyl-butyrylamino}-N-(1-carbamoyl-2-phenyl-ethyl)-succinamic acid
   Show/Hide
C29H36N6O6S
 2
1
EC50 = 1.4 nM
   TI
   LI
   LO
   TS
2
Ki = 93 nM
   TI
   LI
   LO
   TS
CP0375267
(S)-3-((S)-2-{[(S)-2-tert-Butoxycarbonylamino-3-(1H-indol-3-yl)-propionyl]-methyl-amino}-hexanoylamino)-N-((S)-1-carbamoyl-2-phenyl-ethyl)-succinamic acid
   Show/Hide
C36H48N6O8
 4
1
EC50 = 1.5 nM
   TI
   LI
   LO
   TS
2
Ki = 2.6 nM
   TI
   LI
   LO
   TS
3
Ki = 87 nM
   TI
   LI
   LO
   TS
4
Ki > 5000 nM
   TI
   LI
   LO
   TS
CP0404006
(3S)-4-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-[[(2S)-2-[[(2S)-2-(3-carboxypropanoylamino)-3-(1H-indol-3-yl)propanoyl]-methylamino]hexanoyl]amino]-4-oxobutanoic acid
   Show/Hide
C35H44N6O9
 1
1
EC50 = 1.5 nM
   TI
   LI
   LO
   TS
CP0434290
3-(2-{[2-(2-Carbamoyl-acetylamino)-3-(1H-indol-3-yl)-propionyl]-methyl-amino}-hexanoylamino)-N-(1-carbamoyl-2-phenyl-ethyl)-succinamic acid
   Show/Hide
C34H43N7O8
 1
1
EC50 = 1.64 nM
   TI
   LI
   LO
   TS
CP0491828
(3S)-4-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-[[(2S)-2-[[(2S)-3-(1H-indol-3-yl)-2-[(3-methoxy-3-oxopropanoyl)amino]propanoyl]-methylamino]hexanoyl]amino]-4-oxobutanoic acid
   Show/Hide
C35H44N6O9
 1
1
EC50 = 2 nM
   TI
   LI
   LO
   TS
CP0375242
3-(2-{[2-(2-Benzylcarbamoyl-acetylamino)-3-(1H-indol-3-yl)-propionyl]-methyl-amino}-hexanoylamino)-N-(1-carbamoyl-2-phenyl-ethyl)-succinamic acid
   Show/Hide
C41H49N7O8
 1
1
EC50 = 3.3 nM
   TI
   LI
   LO
   TS
CP0437397
3-(2-{[2-(2-{2-[2-tert-Butoxycarbonylamino-3-(4-sulfooxy-phenyl)-propionylamino]-hexanoylamino}-acetylamino)-3-(1H-indol-3-yl)-propionyl]-methyl-amino}-hexanoylamino)-N-(1-carbamoyl-2-phenyl-ethyl)-succinamic acid
   Show/Hide
C53H71N9O15S
 2
1
EC50 = 3.4 nM
   TI
   LI
   LO
   TS
2
Ki = 0.31 nM
   TI
   LI
   LO
   TS
CP0460092
(3S)-4-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-[[(2R,5R)-2-(1H-indol-3-ylmethyl)-2-methyl-3,14-dioxo-1,4-diazacyclotetradecane-5-carbonyl]amino]-4-oxobutanoic acid
   Show/Hide
C36H46N6O7
 2
1
EC50 = 4 nM
   TI
   LI
   LO
   TS
2
Ki = 23 nM
   TI
   LI
   LO
   TS
CP0509168
(3S)-4-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-[[(2R,5R)-2-(1H-indol-3-ylmethyl)-2-methyl-3,13-dioxo-1,4-diazacyclotridecane-5-carbonyl]amino]-4-oxobutanoic acid
   Show/Hide
C35H44N6O7
 2
1
EC50 = 7 nM
   TI
   LI
   LO
   TS
2
Ki = 18 nM
   TI
   LI
   LO
   TS
CP0857895
N-(1-Carbamoyl-2-phenyl-ethyl)-3-{[(5R,8R)-8-(1H-indol-3-ylmethyl)-8-methyl-7,10-dioxo-1,2-dithia-6,9-diaza-cyclotetradecane-5-carbonyl]-amino}-succinamic acid
   Show/Hide
C34H42N6O7S2
 2
1
EC50 = 7 nM
   TI
   LI
   LO
   TS
2
Ki = 80 nM
   TI
   LI
   LO
   TS
CP0506637
(3S)-4-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-[[(2S,5S)-2-(1H-indol-3-ylmethyl)-2-methyl-3,13-dioxo-1,4-diazacyclotridecane-5-carbonyl]amino]-4-oxobutanoic acid
   Show/Hide
C35H44N6O7
 2
1
EC50 = 7 nM
   TI
   LI
   LO
   TS
2
Ki = 18 nM
   TI
   LI
   LO
   TS
CP0402524
3-{2-[2-{[9-tert-Butoxycarbonylamino-3-butyl-2,5,8,11-tetraoxo-6-(4-sulfooxy-benzyl)-1,4,7,12tetraaza-cycloheptadecane-17-carbonyl]-amino}-3-(1H-indol-3-yl)-propionylamino]-hexanoylamino}-N-(1-carbamoyl-2-phenyl-ethyl)-succinamic acid
   Show/Hide
C60H81N11O17S
 2
1
EC50 = 17 nM
   TI
   LI
   LO
   TS
2
Ki = 198 nM
   TI
   LI
   LO
   TS
CP0100788
4-[[(1R)-2-[[(2R)-2-(2-adamantyloxycarbonylamino)-3-(1H-indol-3-yl)-2-methylpropanoyl]amino]-1-phenylethyl]amino]-4-oxobutanoic acid
   Show/Hide
C35H42N4O6
 1
1
Ki = 7.3 nM
   TI
   LI
   LO
   TS
CP0377312
(R)-1-[(R)-2-(Adamantan-2-yloxycarbonylamino)-3-(1H-indol-3-yl)-2-methyl-propionyl]-4-(4-chloro-phenyl)-pyrrolidine-2-carboxylic acid
   Show/Hide
C34H38ClN3O5
 1
1
Ki = 14 nM
   TI
   LI
   LO
   TS
CP0281589
(2S,4S)-1-[(S)-2-(Adamantan-2-yloxycarbonylamino)-3-(1H-indol-3-yl)-2-methyl-propionyl]-4-(2,4-dichloro-phenoxy)-piperidine-2-carboxylic acid
   Show/Hide
C35H39Cl2N3O6
 1
1
Ki = 14 nM
   TI
   LI
   LO
   TS
CP0335897
2-[[(2R)-2-(2-adamantyloxycarbonylamino)-3-(1H-indol-3-yl)-2-methylpropanoyl]-[2-(4-chlorophenyl)ethyl]amino]acetic acid
   Show/Hide
C33H38ClN3O5
 1
1
Ki = 14 nM
   TI
   LI
   LO
   TS
CP0036767
S-L-365,260
   Show/Hide
C24H22N4O2
 1
1
Ki = 15 nM
   TI
   LI
   LO
   TS
CP0441663
(2R,4R)-1-[(R)-2-(2-Aza-tricyclo[3.3.1.1*3,7*]dec-2-yloxycarbonylamino)-3-(1H-indol-3-yl)-2-methyl-propionyl]-4-(2,4-dichloro-phenoxy)-pyrrolidine-2-carboxylic acid
   Show/Hide
C33H36Cl2N4O6
 1
1
Ki = 15.3 nM
   TI
   LI
   LO
   TS
CP0123919
(2R,4R)-1-[(R)-2-(Adamantan-2-yloxycarbonylamino)-3-(1H-indol-3-yl)-2-methyl-propionyl]-4-(2,4-dichloro-phenoxy)-pyrrolidine-2-carboxylic acid
   Show/Hide
C34H37Cl2N3O6
 1
1
Ki = 15.3 nM
   TI
   LI
   LO
   TS
CP0398546
(2R,4R)-1-[(R)-2-(2-Aza-tricyclo[3.3.1.1*3,7*]dec-2-yloxycarbonylamino)-3-(1H-indol-3-yl)-2-methyl-propionyl]-4-(2,4-difluoro-phenoxy)-pyrrolidine-2-carboxylic acid
   Show/Hide
C33H36F2N4O6
 1
1
Ki = 18.6 nM
   TI
   LI
   LO
   TS
CP0149157
(2R,4R)-1-[(R)-2-(Adamantan-2-yloxycarbonylamino)-3-(1H-indol-3-yl)-2-methyl-propionyl]-4-(2,4-difluoro-phenoxy)-pyrrolidine-2-carboxylic acid
   Show/Hide
C34H37F2N3O6
 1
1
Ki = 18.6 nM
   TI
   LI
   LO
   TS
CP0508573
(2R,4R)-1-[(R)-2-(2-Aza-tricyclo[3.3.1.1*3,7*]dec-2-yloxycarbonylamino)-3-(1H-indol-3-yl)-2-methyl-propionyl]-4-(4-fluoro-phenoxy)-pyrrolidine-2-carboxylic acid
   Show/Hide
C33H37FN4O6
 1
1
Ki = 19.9 nM
   TI
   LI
   LO
   TS
CP0505967
(2R,4R)-1-[(R)-2-(Adamantan-2-yloxycarbonylamino)-3-(1H-indol-3-yl)-2-methyl-propionyl]-4-benzyloxy-pyrrolidine-2-carboxylic acid
   Show/Hide
C35H41N3O6
 1
1
Ki = 24 nM
   TI
   LI
   LO
   TS
CP0461292
(2R,4R)-1-[(R)-2-(Adamantan-2-yloxycarbonylamino)-3-(1H-indol-3-yl)-2-methyl-propionyl]-4-phenoxy-pyrrolidine-2-carboxylic acid
   Show/Hide
C34H39N3O6
 1
1
Ki = 28 nM
   TI
   LI
   LO
   TS
CP0437621
(2R,4R)-1-[(R)-2-(2-Aza-tricyclo[3.3.1.1*3,7*]dec-2-yloxycarbonylamino)-3-(1H-indol-3-yl)-2-methyl-propionyl]-4-(4-nitro-phenoxy)-pyrrolidine-2-carboxylic acid
   Show/Hide
C33H37N5O8
 1
1
Ki = 32.7 nM
   TI
   LI
   LO
   TS
CP0209063
(2R,4R)-1-[(R)-2-(Adamantan-2-yloxycarbonylamino)-3-(1H-indol-3-yl)-2-methyl-propionyl]-4-(4-nitro-phenoxy)-pyrrolidine-2-carboxylic acid
   Show/Hide
C34H38N4O8
 1
1
Ki = 32.7 nM
   TI
   LI
   LO
   TS
CP0521115
(2R,4R)-1-[(R)-2-(2-Aza-tricyclo[3.3.1.1*3,7*]dec-2-yloxycarbonylamino)-3-(1H-indol-3-yl)-2-methyl-propionyl]-4-(4-iodo-phenoxy)-pyrrolidine-2-carboxylic acid
   Show/Hide
C33H37IN4O6
 1
1
Ki = 74.9 nM
   TI
   LI
   LO
   TS
CP0945277
(S)-3-(2-{[(S)-2-(2-{2-[2-tert-Butoxycarbonylamino-3-((S)-4-sulfooxy-phenyl)-propionylamino]-hexanoylamino}-acetylamino)-3-(1H-indol-3-yl)-propionyl]-methyl-amino}-hexanoylamino)-N-((S)-1-carbamoyl-2-phenyl-ethyl)-succinamic acid
   Show/Hide
C52H68N9NaO15S
 1
1
Ki = 96 nM
   TI
   LI
   LO
   TS
CP0384196
(3S)-4-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-[[(2R,5R)-2-(1H-indol-3-ylmethyl)-2-methyl-3,12-dioxo-1,4-diazacyclododecane-5-carbonyl]amino]-4-oxobutanoic acid
   Show/Hide
C34H42N6O7
 1
1
Ki = 142 nM
   TI
   LI
   LO
   TS
CP0507769
(2R,4S)-1-[(R)-2-(Adamantan-2-yloxycarbonylamino)-3-(1H-indol-3-yl)-2-methyl-propionyl]-4-(2,4-dichloro-phenoxy)-piperidine-2-carboxylic acid
   Show/Hide
C35H39Cl2N3O6
 1
1
Ki = 175.2 nM
   TI
   LI
   LO
   TS
CP0484574
(2S,4R)-1-[(R)-2-(Adamantan-2-yloxycarbonylamino)-3-(1H-indol-3-yl)-2-methyl-propionyl]-4-(2,4-dichloro-phenoxy)-piperidine-2-carboxylic acid
   Show/Hide
C35H39Cl2N3O6
 1
1
Ki = 543 nM
   TI
   LI
   LO
   TS
CP0496279
(2R,4R)-1-[(R)-2-(Adamantan-2-yloxycarbonylamino)-3-(1H-indol-3-yl)-2-methyl-propionyl]-4-(2,4-dichloro-phenoxy)-piperidine-2-carboxylic acid
   Show/Hide
C35H39Cl2N3O6
 1
1
Ki = 789 nM
   TI
   LI
   LO
   TS
CP0404222
(2S,4S)-1-[(R)-2-(Adamantan-2-yloxycarbonylamino)-3-(1H-indol-3-yl)-2-methyl-propionyl]-4-(2,4-dichloro-phenoxy)-piperidine-2-carboxylic acid
   Show/Hide
C35H39Cl2N3O6
 1
1
Ki = 791 nM
   TI
   LI
   LO
   TS
CP0491331
(2R,4S)-1-[(S)-2-(Adamantan-2-yloxycarbonylamino)-3-(1H-indol-3-yl)-2-methyl-propionyl]-4-(2,4-dichloro-phenoxy)-piperidine-2-carboxylic acid
   Show/Hide
C35H39Cl2N3O6
 1
1
Ki = 812 nM
   TI
   LI
   LO
   TS
CP0529905
(2S,4R)-1-[(S)-2-(Adamantan-2-yloxycarbonylamino)-3-(1H-indol-3-yl)-2-methyl-propionyl]-4-(2,4-dichloro-phenoxy)-piperidine-2-carboxylic acid
   Show/Hide
C35H39Cl2N3O6
 1
1
Ki = 896 nM
   TI
   LI
   LO
   TS
CP0514438
(2R,4R)-1-[(2S)-2-(2-adamantyloxycarbonylamino)-3-(1H-indol-3-yl)-2-methylpropanoyl]-4-(2,4-dichlorophenoxy)piperidine-2-carboxylic acid
   Show/Hide
C35H39Cl2N3O6
 1
1
Ki = 1040 nM
   TI
   LI
   LO
   TS
CP0404592
(2R,4S)-1-[(R)-2-(Adamantan-2-yloxycarbonylamino)-3-(1H-indol-3-yl)-2-methyl-propionyl]-4-(2,4-dichloro-phenoxy)-piperidine-2-carboxylic acid methyl ester
   Show/Hide
C36H41Cl2N3O6
 1
1
Ki = 1538 nM
   TI
   LI
   LO
   TS
CP0163676
2-adamantyl N-[1-(4-benzoylpiperidin-1-yl)-3-(1H-indol-3-yl)-2-methyl-1-oxopropan-2-yl]carbamate
   Show/Hide
C35H41N3O4
 1
1
Ki = 3400 nM
   TI
   LI
   LO
   TS
CP0505643
(S)-N-((S)-1-Carbamoyl-2-phenyl-ethyl)-3-((S)-2-{[(S)-3-(1H-indol-3-yl)-2-(2-pentylcarbamoyl-acetylamino)-propionyl]-methyl-amino}-hexanoylamino)-succinamic acid
   Show/Hide
C39H53N7O8
 1
1
Ki = 3640 nM
   TI
   LI
   LO
   TS